- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00499915
NICU Asthma Education and Secondhand Smoke Reduction Study
Preventing Respiratory Illness Among Premature Infants: An Asthma Education and Secondhand Smoke Reduction Study
Premature infants have a significantly increased risk for developing respiratory illnesses and asthma. Secondhand smoke (SHS) also is clearly associated with increased breathing problems in children, thus exposure to smoke makes it substantially more likely for a premature infant to develop wheezing. The overall goal of this study is to test whether comprehensive asthma education combined with a home-based secondhand smoke reduction program can reduce exposure to smoke and prevent respiratory illness among premature infants. Our hypotheses are:
- More premature infants whose families receive asthma education combined with a SHS reduction intervention will live in smoke-free environments compared to infants receiving only asthma education (control group).
- Caregivers receiving the SHS reduction program will have higher rates of quit attempts and less relapse into smoking compared to caregivers in the control group.
- Infants whose families receive the combined intervention will experience less respiratory illness compared to infants in the control group.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Rochester, New York, United States, 14642
- University of Rochester
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ≤32 weeks gestation
- Planned discharge to home from the Neonatal Intensive Care Unit
- Parent or caregiver must consent to the intervention
- The first sibling discharged, for twins or infants from a multiple birth pregnancy
Exclusion Criteria:
- Inability to speak and understand English
- No access to a working phone for follow-up surveys (either at the subject's home or an easily accessible alternate home)
- Family residence outside the greater Rochester area (more than 30 miles away)
- Children in foster care or other situations in which guardian consent cannot be obtained
- The child having significant medical conditions, including serious heart disease, cystic fibrosis, or other conditions that could interfere with the assessment of respiratory-related outcome measures
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Secondhand Smoke Reduction and Asthma Education
Parents of children in the experimental group will receive asthma education at NICU discharge as well as a secondhand smoke reduction program.
|
A secondhand smoke reduction program, including smoking cessation counseling (if appropriate), and feedback about the children's cotinine levels will be implemented using principles of Motivational Interviewing.
Asthma education will be provided at NICU discharge.
|
|
Active Comparator: Asthma Education
Parents of children in the active comparator group will receive asthma education at NICU discharge.
|
Asthma education will be provided at NICU discharge.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Infants Living in Smoke-free Environments.
Time Frame: 5 months post baseline
|
Infants living in homes with a "home smoking ban" rule
|
5 months post baseline
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Respiratory Morbidity Assessed Through Respiratory Symptoms as Well as Health Care Utilization for Respiratory Illnesses.
Time Frame: 2, 5, and 7-9 months post baseline
|
2, 5, and 7-9 months post baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jill S. Halterman, MD, MPH, University of Rochester
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 15214
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.